Published financial brief
0152B
CABALETTA BIO INC
- As of
- 2024-12-31
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
4 data notes
- Input provenance requires review.
- A ratio denominator is near zero.
- One or more values are unavailable.
- A displayed ratio exceeds the warning bound.
Exact-period record
Fundamentals
5 reported periods
| Metric | FY 20202020-12-31 | FY 20212021-12-31 | FY 20222022-12-31 | FY 20232023-12-31 | FY 20242024-12-31 |
|---|---|---|---|---|---|
| Financial statements | |||||
| RevenueUSD millions | 0 | 0 | 0 | 0 | 0 |
| Cost of goods soldUSD millions | 0 | 0 | 0 | 0 | 0 |
| Selling, general and administrative expenseUSD millions | 33.5 | 45.6 | 53 | 73.2 | 120.3 |
| Depreciation and amortizationUSD millions | 0.4 | 0.7 | 1.2 | 1.4 | 4.8 |
| Net incomeUSD millions | -33.3 | -46.3 | -53 | -67.7 | -115.9 |
| Operating profit (EBIT)USD millions | -33.8 | -46.3 | -54.1 | -74.7 | -125.1 |
| Income taxesUSD millions | 0 | 0 | 0 | 0 | 0 |
| Short-term debtUSD millions | 0 | 0 | 2.2 | 3.6 | 10 |
| Long-term debtUSD millions | 0 | 0 | 3 | 1.5 | 5.6 |
| Cash and equivalentsUSD millions | 108.7 | 122.2 | 106.6 | 241.3 | 164 |
| ReceivablesUSD millions | 0 | 0 | 0 | 0 | 0 |
| InventoryUSD millions | 0 | 0 | 0 | 0 | 0 |
| PayablesUSD millions | 1.2 | 2.3 | 2.5 | 4.5 | 4.9 |
| Net property, plant and equipmentUSD millions | 0.9 | 1.4 | 7.6 | 7.5 | 16.1 |
| Capital expenditureUSD millions | 0.6 | 1.2 | 2.5 | 0.7 | 2.2 |
| Operating cash flowUSD millions | -26.8 | -34.1 | -46.4 | -53.5 | -88.2 |
| Prepaid expensesUSD millions | —missing | —missing | —missing | —missing | —missing |
| AccrualsUSD millions | 3.9 | 6 | 4.8 | 7.8 | 12.1 |
| EBITDAUSD millions | -33.5 | -45.6 | -53 | -73.2 | -120.3 |
| Working capitalUSD millions | 108.4 | 116.2 | 99.3 | 228.5 | 139.6 |
| Working capital requirementUSD millions | -1.2 | -2.3 | -2.5 | -4.5 | -4.9 |
| Total debtUSD millions | 0 | 0 | 5.1 | 5 | 15.6 |
| Free cash flowUSD millions | -27.4 | -35.3 | -48.8 | -54.2 | -90.4 |
| Unlevered free cash flowUSD millions | -33.8 | -45.7 | -55.3 | -71.8 | -122.2 |
| Returns and ratios | |||||
| ROICratio | 9,584.4% | 5,174.6% | -1,060.3% | -2,570.9% | -1,121.8% |
| Pre-tax ROICratio | 9,584.4% | 5,174.6% | -1,060.3% | -2,570.9% | -1,121.8% |
| Effective tax rateratio | 0% | 0% | 0% | 0% | 0% |
| Revenue growthratio | —missing | —missing | —missing | —missing | —missing |
| EBIT / Revenueratio | —missing | —missing | —missing | —missing | —missing |
| Revenue / Invested capitalmultiple | 0× | 0× | 0× | 0× | 0× |
| Cogs Over Revenuesratio | —missing | —missing | —missing | —missing | —missing |
| Sga Over Revenuesratio | —missing | —missing | —missing | —missing | —missing |
| Da Over Revenuesratio | —missing | —missing | —missing | —missing | —missing |
| Nfa Over Revenuesratio | —missing | —missing | —missing | —missing | —missing |
| Wcr Over Revenuesratio | —missing | —missing | —missing | —missing | —missing |
| Debt Over Ebitdamultiple | —missing | —missing | —missing | —missing | —missing |
| St Debt Over Cashmultiple | 0× | 0× | 0.02× | 0.01× | 0.06× |
| Interest Over Ebitdamultiple | —missing | —missing | —missing | —missing | —missing |
| Interest Over Nocf Nicfmultiple | 0× | 0× | 0× | 0× | -0.01× |
| Nsf Over Wcrmultiple | 87.42× | 52.39× | 42.37× | 52.27× | 31.28× |
Ask this snapshot
Research assistant
0152B · annualSnapshot 49cd1c41
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000